TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/25/24 16:21 | 10/23/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NY | O | CTO | S | -81 | 29.53 | 0 | -3 | -2 | 142 | D | ||||||||||||||
7/26/24 16:20 | 7/24/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NY | O | CTO | S | -78 | 27.76 | 0 | -3 | -2 | 145 | D | ||||||||||||||
4/26/24 17:20 | 4/24/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NY | O | CTO | S | -209 | 28.90 | 0 | -7 | -5 | 148 | D | ||||||||||||||
4/25/18 18:10 | 4/24/18 | VSAR | Versartis, Inc. | Health | Drug | Pharmaceutical Preparations | Stout Jay S | CA | O | SVP,Tech | S | -8 | 1.55 | 0 | -5 | -3 | 186 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |